- Trials with a EudraCT protocol (501)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (145)
501 result(s) found for: Magnesium.
Displaying page 1 of 26.
| EudraCT Number: 2007-001131-61 | Sponsor Protocol Number: no sponsor | Start Date*: 2007-06-20 | |||||||||||
| Sponsor Name:Belgian Group of Digestive Oncology | |||||||||||||
| Full Title: A national randomised multi-centre trial to assess the effect of oral magnesium supplementation on the kinetics of magnesium wasting induced by EGFR targeted antibody therapy for colorectal carcino... | |||||||||||||
| Medical condition: To evaluate the effect and tolerability of high dose Mg gluconate oral substitution in the (1) prevention and (2) treatment of magnesium wasting due to anti-EGFR treatment in colorectal cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-001243-27 | Sponsor Protocol Number: 77108 | Start Date*: 2021-12-09 |
| Sponsor Name:Radboudumc | ||
| Full Title: Effect of oral magnesium supplementation on insulin sensitivity in people with type 2 diabetes | ||
| Medical condition: People with type 2 diabetes mellitus who are treated with insulin and have a low serum magnesium concentration | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2022-000596-40 | Sponsor Protocol Number: 112930 | Start Date*: 2023-01-10 |
| Sponsor Name:Radboudumc | ||
| Full Title: Effect of dapaglifozin on serum magnesium in HNF1β patients with renal hypomagnesemia | ||
| Medical condition: Renal hypomagnesemia in ADTKD-HNF1β patients | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-003749-24 | Sponsor Protocol Number: MGLACC07810 | Start Date*: 2016-03-03 |
| Sponsor Name:Sanofi-Aventis Group | ||
| Full Title: Effects of MagneB6® (470.0 mg Magnesium Lactate Dihydrate + 5.0 mg Pyridoxine Hydrochloride, Coated Tablet) Supplementation (8 Weeks) on Stress Levels of Chronically Stressed Subjects, with Subopti... | ||
| Medical condition: | ||
| Disease: | ||
| Population Age: | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-002818-11 | Sponsor Protocol Number: 2003AN004 | Start Date*: 2004-12-08 |
| Sponsor Name:Heart of England NHS Foundation Trust | ||
| Full Title: Magnesium Sulphate for the Prevention of Super Ventricular Dysrrhythmias following Non-Cardiac Thoracic Surgery | ||
| Medical condition: Post Thoracotomy Super Ventricular Dysrhythmias | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-001634-10 | Sponsor Protocol Number: SARO.21.001 | Start Date*: 2023-01-23 | |||||||||||
| Sponsor Name:Zydus Therapeutics Inc. | |||||||||||||
| Full Title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2b/3 Study to Evaluate the Efficacy and Safety of Saroglitazar Magnesium in Subjects with Primary Biliary Cholangitis. | |||||||||||||
| Medical condition: Primary biliary Cholangitis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2006-002484-99 | Sponsor Protocol Number: 2006 | Start Date*: 2007-01-10 |
| Sponsor Name:South Devon Health Care NHS Foundation Trust | ||
| Full Title: The Use of Nebulised Magnesium Sulphate in Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) | ||
| Medical condition: We propose a study to examine whether adjuvant magnesium therapy administered via nebuliser is effective in the management of patients with acute exacerbations of COPD. The findings should help to ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-003417-41 | Sponsor Protocol Number: 271165 | Start Date*: 2006-09-07 |
| Sponsor Name:Medical Centre Leeuwarden | ||
| Full Title: The effect of nebulised MgSO4 on lung function in stable severe asthma patients with persistent airflow limitation | ||
| Medical condition: Patients with severe asthma and persistent airflow limitation | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-003790-41 | Sponsor Protocol Number: JAN12006-01 | Start Date*: 2015-05-11 |
| Sponsor Name:Spherium Biomed | ||
| Full Title: Randomised, double-blinded, placebo and active comparator controlled exploratory clinical trial to assess the efficacy and safety of a triple combination of Ibuprofen, magnesium and ascorbic acid ... | ||
| Medical condition: Temporomandibular joint dysfunction syndrome. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-004005-24 | Sponsor Protocol Number: EC04-2010 | Start Date*: 2012-11-06 |
| Sponsor Name:Complejo Hospitalario Torrecárdenas | ||
| Full Title: | ||
| Medical condition: Postoperative pain. Hypomagnesemia in surgical patients. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-015783-34 | Sponsor Protocol Number: ID 2770 | Start Date*: 2009-12-23 |
| Sponsor Name:AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA | ||
| Full Title: Effects of Magnesium on Blood Pressure in Patients with familiarity for Metabolic Syndrome | ||
| Medical condition: familiarity for matabolic syndrome | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: IT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-005454-35 | Sponsor Protocol Number: MG001 | Start Date*: 2013-03-13 | |||||||||||
| Sponsor Name:Hanna Pitkänen | |||||||||||||
| Full Title: Can magnesium enhance blood coagulation amongst patients with alcohol induced liver cirrhosis? | |||||||||||||
| Medical condition: Liver transplant candidates with alcohol induced liver cirrhosis and hypomagnesemia (P-Mg under 0,71 or magnesium substitution at least 750 mg/day) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FI (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2007-001187-78 | Sponsor Protocol Number: 112897 | Start Date*: 2008-01-02 | |||||||||||
| Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | |||||||||||||
| Full Title: The 3Mg Trial: A randomised controlled trial of intravenous or nebulised magnesium sulphate versus standard therapy for acute severe asthma | |||||||||||||
| Medical condition: Acute severe asthma | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2004-002850-69 | Sponsor Protocol Number: IGPM01 | Start Date*: 2006-01-06 |
| Sponsor Name:Swansea NHS Trust | ||
| Full Title: Role of High dose insulin and glucose-potassium-magnesium (HDI-GKM) for Myocardial protection in cardiac surgery | ||
| Medical condition: We propose to recruit 90 patients (based on the power calculation) undergoing first time urgent in-house CABG at Morriston Hospital. The decision to operate on an urgent basis will be based on the ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-002824-19 | Sponsor Protocol Number: NA | Start Date*: 2021-08-12 |
| Sponsor Name:CHU de Liège | ||
| Full Title: Study of the hypnotic and anti-nociceptive components of Magnesium using Electroencephalogram Spectral Entropy and pupillometry during total intravenous general anesthesia : a randomized double-bli... | ||
| Medical condition: Total thyroidectomy | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-000735-80 | Sponsor Protocol Number: 2010-382 | Start Date*: 2011-05-16 |
| Sponsor Name:Lene Drasbek Huusom | ||
| Full Title: Administration of antenatal magnesium sulphate for prevention of cerebral palsy in preterm infants (MASP-STUDY) | ||
| Medical condition: Moderate to severe cerebral palsy | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: DK (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-000408-36 | Sponsor Protocol Number: 08440012010002 | Start Date*: 2022-10-25 | |||||||||||
| Sponsor Name:ZonMw | |||||||||||||
| Full Title: OMAMA-study – prevention of opioid-induced constipation in patients with advanced cancer | |||||||||||||
| Medical condition: Opioid-induced constipation in patients with advanced cancer, starting with opioids for pain | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2006-003523-36 | Sponsor Protocol Number: 2005B016 | Start Date*: 2007-07-30 |
| Sponsor Name:Netherlands Heart Foundation | ||
| Full Title: Magnesium in Aneurysmal Subarachnoid Haemorrhage | ||
| Medical condition: Aneurysmal subarachnoid haemorrhage | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-004898-14 | Sponsor Protocol Number: MgSO4-konc | Start Date*: 2018-04-03 |
| Sponsor Name:Sahlgrenska University Hospital | ||
| Full Title: See down below. | ||
| Medical condition: Please see below | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-013294-18 | Sponsor Protocol Number: 2009-06-01 | Start Date*: 2010-08-02 |
| Sponsor Name:Universitätsklinikum Greifswald der Ernst-Moritz-Arndt Universität Greifswald AöR | ||
| Full Title: Magnesiumsulfate in the prevention of post-ERCP pancreatitis – a prospective randomized, placebo-controlled multicenter study | ||
| Medical condition: Post-ERCP pancreatitis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) HU (Ongoing) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
